Covalon Technologies Ltd. (COV.V)
1.84
-0.13
(-6.60%)
CAD |
TSXV |
Dec 11, 15:50
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 50.45M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | -40.82% |
| Valuation | |
| PE Ratio | 22.14 |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | 1.551 |
| Price to Book Value | 1.700 |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | 0.15 |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | 0.0431 |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 88.13% |
Profile
| Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of patent-protected medical products. It focuses on wound care, infection management, and surgical procedures. The firm sells its products under the brand name Covalon. Its products categories include advanced wound care, vascular access, perioperative care, and urology. The company was founded on April 28, 2004 and is headquartered in Mississauga, Canada. |
| URL | http://www.covalon.com |
| Investor Relations URL | http://ir.covalon.com/phoenix.zhtml?c=183092&p=irol-IRHome |
| HQ State/Province | Ontario |
| Sector | Health Care |
| Industry | Biotechnology |
| Next Earnings Release | Dec. 11, 2025 |
| Last Earnings Release | Dec. 11, 2025 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Nov. 04, 2025 |
Ratings
Profile
| Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of patent-protected medical products. It focuses on wound care, infection management, and surgical procedures. The firm sells its products under the brand name Covalon. Its products categories include advanced wound care, vascular access, perioperative care, and urology. The company was founded on April 28, 2004 and is headquartered in Mississauga, Canada. |
| URL | http://www.covalon.com |
| Investor Relations URL | http://ir.covalon.com/phoenix.zhtml?c=183092&p=irol-IRHome |
| HQ State/Province | Ontario |
| Sector | Health Care |
| Industry | Biotechnology |
| Next Earnings Release | Dec. 11, 2025 |
| Last Earnings Release | Dec. 11, 2025 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Nov. 04, 2025 |